Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;25(1):366-373.
doi: 10.1111/hex.13393. Epub 2021 Dec 2.

Development and field testing of a decision aid to facilitate shared decision making for adults newly diagnosed with attention-deficit hyperactivity disorder

Yumi Aoki  1 , Takashi Tsuboi  2 , Yoshikazu Takaesu  2   3 , Koichiro Watanabe  2 , Kazuhiro Nakayama  1 , Yasuhito Kinoshita  1 , Mami Kayama  1
Affiliations

Development and field testing of a decision aid to facilitate shared decision making for adults newly diagnosed with attention-deficit hyperactivity disorder

Yumi Aoki et al. Health Expect. 2022 Feb.

Abstract

Background: The number of individuals who are diagnosed with attention-deficit hyperactivity disorder (ADHD) during adulthood has increased in recent years. However, there is still no decision aid (DA) to help adults newly diagnosed with ADHD make decisions regarding further treatments.

Objective: This study aimed to describe the development process of a DA for adults newly diagnosed with ADHD and its field testing during the shared decision-making (SDM) process in a clinical setting.

Methods: The development process involved the creation of a DA prototype using the International Patient Decision Aid Standards criteria and revision of the prototype through the stakeholders' reviews. The field testing of the DA compared scores before and after the SDM process on the service users' knowledge scale, decisional conflict scale and the Conners Adult ADHD Rating Scales.

Results: The developed DA contained options of watchful waiting with own coping skills and pharmacological treatment, which consisted of several kinds of drug options. Fifteen adults newly diagnosed with ADHD participated in the field testing. The participant decision-making quality outcomes such as their knowledge and decisional conflict improved after the SDM process. ADHD severity did not change.

Conclusion: A DA for adults with ADHD was systematically developed following the international criteria. Field testing indicated that the DA could serve as a tool to facilitate the SDM process. Further research on this DA is necessary before its routine implementation.

Patient or public contribution: During the development process of the DA, the service users who had already been diagnosed with ADHD reviewed the DA prototype and provided feedback, which improved the final version of the DA.

Keywords: attention-deficit hyperactivity disorder; decision aid; pre-post test; shared decision making; treatment decision making.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Similar articles

See all similar articles

Cited by

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental of Mental Disorders. 5th ed. American Psychiatric Publishing; 2013.
    1. Faraone SV, Biederman J, Mick E. The age‐dependent decline of attention deficit hyperactivity disorder: a meta‐analysis of follow‐up studies. Psychol Med. 2006;379:159‐165. - PubMed
    1. Simon V, Czobor P, Bálint S, Mészáros A, Bitter I. Prevalence and correlates of adult attention‐deficit hyperactivity disorder: meta‐analysis. Br J Psychiatry. 2009;01194:204‐211. - PubMed
    1. Doshi JA, Hodgkins P, Kahle J, et al. Economic impact of childhood and adult attention‐deficit/hyperactivity disorder in the United States. J Am Acad Child Adolesc Psychiatry. 2012;51:990‐1002. - PubMed
    1. National Institute for Health and Clinical Excellence (NICE) . Attention deficit hyperactivity disorder: diagnosis and management NICE guideline [NG87]. 2019. Accessed October 4, 2021. https://www.nice.org.uk/guidance/ng87/chapter/Recommendations - PubMed

Publication types